Related Experiment Video
Updated: Aug 7, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Women and HIV: when to test?
J A Larkin1, K Minerva, D Holt
1Division of Infectious Diseases and Tropical Medicine, University of South Florida College of Medicine, Tampa, Florida, USA.
The AIDS Reader
|May 6, 2003
Summary
New therapies can significantly alter the impact of human immunodeficiency virus (HIV) in women. This review highlights clinical signs that may indicate a need for HIV testing, aiding early diagnosis and treatment.
Area of Science:
- Infectious Diseases
- Women's Health
- Clinical Medicine
Background:
- Human immunodeficiency virus (HIV) infection presents unique challenges in women.
- Early identification of HIV is crucial for effective management and improved outcomes.
- Advancements in therapy offer new hope for managing HIV in affected individuals.
Observation:
- Certain clinical presentations strongly suggest the need for HIV testing in women.
- These include oral thrush, diffuse lymphadenopathy, unexplained fevers, wasting, and oral hairy leukoplakia.
- The article also explores less common, gender-specific and non-gender-specific syndromes.
Findings:
- A comprehensive understanding of clinical syndromes can guide practitioners in considering HIV testing.
- Recognizing subtle or atypical signs is essential for timely diagnosis.
- Prompting HIV testing based on a broader range of symptoms can benefit patient care.
Implications:
- Timely HIV diagnosis through recognition of diverse clinical syndromes can lead to earlier treatment initiation.
- This can dramatically alter the devastating effects of HIV infection in women.
- Improved patient outcomes and quality of life are achievable with prompt and appropriate medical intervention.
Related Concept Videos
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.